BackNeos Therapeutics Overview

Neos Therapeutics Selling, General & Admin

Selling, General & Admin expenses for NEOS.

Quarterly SG&A Expenses

$9.02M
↓ 9.56% YoY

As of Sep 30, 2020

Annual SG&A Expenses (TTM)

$39.33M
↓ 11.2% YoY

Trailing 12 months ending Sep 30, 2020

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin